These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15122752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [Abstract] [Full Text] [Related]

  • 4. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H, Cooper C, Murphy T, Klein MB.
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [Abstract] [Full Text] [Related]

  • 5. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B.
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [Abstract] [Full Text] [Related]

  • 11. Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
    Benlloch S, Heredia L, Barquero C, Rayón JM, Pina R, Aguilera V, Prieto M, Berenguer M.
    Liver Transpl; 2009 Dec; 15(12):1798-807. PubMed ID: 19938146
    [Abstract] [Full Text] [Related]

  • 12. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL, Xiao YQ, Chen F.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [Abstract] [Full Text] [Related]

  • 13. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 14. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA, Fernández-Varo G, Bruguera M, García-Pagán JC, García-Valdecasas JC, Pérez-Del-Pulgar S, Forns X, Jiménez W, Navasa M.
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [Abstract] [Full Text] [Related]

  • 15. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T, MULTIVIRC Group. Groupe d'Etude Multidisciplinaire sur les Pathologies Liées au Virus C.
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [Abstract] [Full Text] [Related]

  • 17. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 18. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR, VA HCV-001 Study Group.
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [Abstract] [Full Text] [Related]

  • 19. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J.
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [Abstract] [Full Text] [Related]

  • 20. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G, Vario A, Guido M, Alberti A.
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.